The effect of vitamin B12 and folic acid supplementation on the treatment of multiple sclerosis
Not Applicable
- Conditions
- Multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT2015100313678N7
- Lead Sponsor
- Vice chancellor for research, Urmia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
patients with relapsing-remitting multiple sclerosis diagnosed with McDonald criteria; 20 to 40 age interval
Exclusion criteria: other kind of neurological diseases or severe depression; kidney disorders; patients with traumatic brain injuries; cardiovascular disease; vitamin B6, vitamin B12, folic acid, choline or betaine consumption during the last six months
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ife quality. Timepoint: Before and after the intervention. Method of measurement: MSQOL-54 standard questionnaire, persian edition.;Serum homocysteine. Timepoint: Before and after the intervention. Method of measurement: Blood test.;Hemoglobin. Timepoint: Before and after the intervention. Method of measurement: Blood test.;MCV. Timepoint: Before and after the intervention. Method of measurement: Blood test.;MCHC. Timepoint: Before and after the intervention. Method of measurement: Blood test.
- Secondary Outcome Measures
Name Time Method